Aims: This study was conducted to evaluate the prevalence, co-infection and socio-demographic determinants of malaria and typhoid fever among pregnant women attending antenatal care at a primary health care facility in Central Nigeria.
Study Design: The study was a cross sectional study.
Place and Duration of Study: Keffi, Nasarawa State, between January and October, 2020.
Methodology: Blood sample (4 ml) was collected from each of the 429 consenting pregnant women attending antenatal care at Primary Healthcare Centre main market, Keffi, Nasarawa State. Malaria parasite was detected from the blood samples using one-step malaria rapid diagnostic test kit (SD Bioline, Inc, USA) and was confirmed by Gimesa stained thin and thick film microscopy while typhoid fever was diagnosed using Cromatest widal commercial antigen suspension (Linear Chemicals, Barcelona, Spain). Data collected were analysed using Smith’s Statistical Package (version 2.8, California, USA) and P value of ≤ 0.05 was considered statistically significant.
Results: Of the 429 pregnant women screened, 123(28.7%) had malaria, 33(7.7%) had typhoid fever while 12(2.8%) had malaria-typhoid co-infection. Malaria-typhoid co-infection was found to be higher among pregnant women aged ≤30 years (3.5%), traders (3.9%), with primary education (3.2%) and who were from rural areas (6.3%). However, only location of the pregnant women was associated with the rate of malaria-typhoid co-infection (P< 0.05) whereas age, educational status and occupation were independent of the co-infection (P> 0.05).
Conclusion: We confirmed the presence of malaria-typhoid co-infection among pregnant women in the study area. Considering it adverse effects on pregnancy and it outcome, there is need for more efforts towards it prevention, control and management.
Aims: This study was conducted to determine the parallel and concurrent infection of dengue virus and Plasmodium falciparum among patients with febrile illnesses attending Bingham University Health Centre, Karu, Nigeria.
Study Design: The study was a cross sectional study.
Place and Duration of Study: Department of Medical Microbiology and Parasitology, Jos University Teaching Hospital, Jos, Department of Microbiology, Nasarawa State University, Keffi and 68 Nigerian Army Reference Hospital, Yaba-Lagos, between February and July 2017.
Methodology: Blood samples were collected from 400 patients with febrile illnesses at the University Health Centre. The resulting sera was screened for dengue virus seromarkers (IgM, IgG and NS1) using Aria Dou dengue virus RDT kits (CTK Biotech, Inc, San Diego, USA) while malaria parasitemia was detected by Giemsa stained thick and thin film microscopy. Data collected were analysed using Smith’s Statistical Package (version 2.8, California, USA) and P value of ≤ 0.05 was considered statistically significant.
Results: Of the 400 patients screened, 12(3.0%) were positive for dengue virus, 20(5.0%) for malaria parasite while 10(2.5%) for dengue/malaria co-infection. Infection with dengue virus and malaria parasite was found to be higher among female subjects aged ≤30 years. However, age and gender were not significantly associated with both infections in this study (P > 0.05).
Conclusion: Our findings confirmed the presence of dengue virus infection in the study area which probably may have been misdiagnosed and mistreated. Hence, differential diagnosis of febrile illnesses should not only be limited to malaria and typhoid as is always the case in our health care centres.
Prevalence and determinants of hepatitis B virus infection among human immunodeficiency virus patients at a tertiary health care facility in Central Nigeria
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.